CRP and non-small cell lung carcinoma: Lastly, while this association has been made for monotherapy CPI, the association between serial CRP decrease and outcomes to chemotherapy combination regimens with CPI is worth assessing as these are the new standard of care regimens for front-line NSCLC patients [23, 24].